10x Genomics, Inc. TXG Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s deferred tax assets and other non-current assets?
- 10x Genomics, Inc. (TXG) reported deferred tax assets and other non-current assets of $2.62M in Q1 2026.
- How has 10x Genomics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- 10x Genomics, Inc.'s deferred tax assets and other non-current assets increased by 14.3% year-over-year, from $2.3M to $2.62M.
- What is the long-term trend for 10x Genomics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s deferred tax assets and other non-current assets has grown at a -7.6% compound annual growth rate (CAGR), from $4.32M to $2.91M.